Human prostate-specific antigen (APS) is a member of the glandular kallikrein gene family at 19q13
- 1 January 1988
- journal article
- research article
- Published by S. Karger AG in Cytogenetic and Genome Research
- Vol. 48 (4), 205-207
- https://doi.org/10.1159/000132629
Abstract
The amino acid sequence of human prostate-specific antigen (APS) suggests that it is a member of the glandular kallikrein subfamily of serine proteases. In the mouse, the kallikrein-like family is localized in a single locus on chromosome 7, while other serine proteases are distributed over a variety of different chromosomes. To investigate the physical relationship between the human kallikrein genes, we have used in situ hybridization and Southern analysis of a human × mouse somatic cell hybrid panel to map the APS gene to 19q13, concordant with the renal kallikrein KLK 1 gene. This finding indicates that APS is a member of a human kallikrein-like gene family with analogous organization to that of the mouse.Keywords
This publication has 15 references indexed in Scilit:
- Localization of the human haptoglobin genes distal to the fragile site at 16q22 using in situ hybridizationCytogenetic and Genome Research, 1986
- A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.Journal of Clinical Investigation, 1985
- Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectorsGene, 1985
- Isolation and sequence of a rat chymotrypsin B gene.Journal of Biological Chemistry, 1984
- Chromosomal assignments of genes for trypsin, chymotrypsin B, and elastase in mouseSomatic Cell and Molecular Genetics, 1984
- A Major Sex Difference in Kallikrein-Like Activity in the Rat Anterior Pituitary*Endocrinology, 1984
- Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptidesNature, 1983
- Multiple Marker Evaluation in Human Prostate Cancer With the Use of Tissue-Specific Antigens23JNCI Journal of the National Cancer Institute, 1982
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977